Genetic variants regulate NR1H3 expression and contribute to multiple sclerosis risk

J Neurol Sci. 2018 Jul 15:390:162-165. doi: 10.1016/j.jns.2018.04.037. Epub 2018 Apr 22.

Abstract

A recent study analyzed 2053 multiple sclerosis (MS) cases and 799 healthy controls to investigate whether five genetic variants (rs11039149, rs12221497, rs2279238, rs7120118 and rs7114704) in NR1H3 are associated with MS risk. However this study reported negative results. It is very important that the appropriate samples and approach should be used in replication studies, which may provide the correct interpretation of the results. Here, we evaluated the above findings using large-scale MS genome-wide association studies with a total of 27,148 samples including 9772 MS cases and 17,376 controls, and multiple expression quantitative trait loci datasets. The results suggest that rs7120118 and rs2279238 variants are significantly associated with MS risk, and could significantly regulate NR1H3 expression in kinds of human tissues and cells. In summary, these findings provide important supplementary information about the association between NR1H3 variants and MS risk.

Keywords: Expression quantitative trait loci; Genome-wide association studies; Multiple sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / metabolism
  • Gene Expression
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study
  • Humans
  • Liver X Receptors / genetics*
  • Liver X Receptors / metabolism*
  • Multiple Sclerosis / genetics*
  • Multiple Sclerosis / metabolism*
  • Polymorphism, Single Nucleotide*
  • Quantitative Trait Loci
  • White People / genetics

Substances

  • Liver X Receptors
  • NR1H3 protein, human